Company news

Medexus Pharmaceuticals Inc. news in 2026

Medexus Pharmaceuticals Inc.'s news releases, calls and decks from 2026, newest first.

View company

Medexus Schedules Second Fiscal Quarter 2027 Conference Call

November 3, 2026

Xeris Biopharma Welcomes Menassie M. Taddese to Board of Directors

November 2, 2026

Medexus Announces Fiscal Q1 2027 Results With Strongest Quarter of Product-Level Performance of GRAFAPEX (Treosulfan) to Date

August 10, 2026

Medexus Schedules First Fiscal Quarter 2027 Conference Call

July 30, 2026

Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection

June 25, 2026

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call

June 16, 2026

Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada

June 9, 2026

Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation

April 15, 2026

Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection

February 11, 2026

Medexus Schedules Third Fiscal Quarter 2026 Conference Call

February 3, 2026

Calls in 2026

Decks in 2026